Free Trial

Quantinno Capital Management LP Has $2.28 Million Stake in Centene Co. (NYSE:CNC)

Centene logo with Medical background

Quantinno Capital Management LP decreased its holdings in shares of Centene Co. (NYSE:CNC - Free Report) by 67.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 37,604 shares of the company's stock after selling 78,075 shares during the quarter. Quantinno Capital Management LP's holdings in Centene were worth $2,278,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Capital Advisors Ltd. LLC lifted its stake in shares of Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock valued at $25,000 after purchasing an additional 177 shares during the period. Hurley Capital LLC acquired a new position in Centene in the fourth quarter valued at about $26,000. Rialto Wealth Management LLC bought a new position in Centene during the fourth quarter worth about $30,000. OFI Invest Asset Management acquired a new position in shares of Centene during the 4th quarter worth about $33,000. Finally, SRS Capital Advisors Inc. raised its position in shares of Centene by 73.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company's stock valued at $38,000 after acquiring an additional 267 shares during the period. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Wells Fargo & Company lowered their target price on shares of Centene from $76.00 to $72.00 and set an "overweight" rating for the company in a research note on Friday, February 14th. Wall Street Zen downgraded Centene from a "strong-buy" rating to a "buy" rating in a research note on Monday, April 28th. Argus cut Centene from a "buy" rating to a "hold" rating in a research note on Thursday, February 6th. Robert W. Baird dropped their price target on Centene from $71.00 to $69.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 15th. Finally, Guggenheim reissued a "neutral" rating on shares of Centene in a research note on Tuesday, April 29th. Seven research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. According to data from MarketBeat, Centene has an average rating of "Moderate Buy" and a consensus price target of $79.77.

Check Out Our Latest Stock Analysis on Centene

Centene Price Performance

CNC stock traded down $1.65 during mid-day trading on Monday, hitting $56.43. The stock had a trading volume of 5,205,572 shares, compared to its average volume of 4,894,312. The firm has a fifty day simple moving average of $60.76 and a 200 day simple moving average of $60.31. Centene Co. has a 52 week low of $55.03 and a 52 week high of $80.59. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $28.08 billion, a P/E ratio of 9.04, a P/E/G ratio of 0.80 and a beta of 0.48.

Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.52 by $0.38. The business had revenue of $46.62 billion during the quarter, compared to the consensus estimate of $43.16 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. The company's revenue was up 15.4% on a year-over-year basis. During the same period in the previous year, the business earned $2.26 earnings per share. As a group, research analysts forecast that Centene Co. will post 6.86 EPS for the current year.

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Articles

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines